112th ASCPT Annual Meeting

Posted:
9
February 2011

Come see us at booth number 528 for this year�s 112th ASCPT Annual Meeting, the premier event for clinical pharmacologists, taking place 2nd to 5th March 2011 in Dallas, Texas.What�s on offer?

  • Over 30 educational sessions and 300 poster presentations
  • Lectures from top professionals in the industry
  • Networking opportunities with clinical pharmacologists from  around the world

Dr J rg fT ubel, medical practitioner and CEO of Richmond Pharmacology, will be presenting two of Richmond Pharmacology s latest publications centred on the following key areas of discussion:

  • COMPARISON OF DIGITAL 12-LEAD ECG AND DIGITAL 12-LEAD HOLTER ECG RECORDINGS IN HEALTHY MALE SUBJECTS - Poster Number: PI-08, scheduled on 3/3/2011 from 8:00 AM
  • FOOD EFFECT ON QTC INTERVAL IN THOROUGH QT STUDIES CONDUCTED IN HEALTHY SUBJECTS - Poster Number: LBII-1, scheduled on 4/3/2011 from 8.00 AM to 9.30 AM

For further details, please refer to the online brochure for program highlights, a schedule of events, student and trainee events.We look forward to seeing you in Dallas!

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more